Evaluation of Screening Tests for Cognitive Impairment in Patients Receiving Maintenance Hemodialysis
Evaluation of Screening Tests for Cognitive Impairment in Patients Receiving Maintenance Hemodialysis
复制标题
DOI:
10.1681/asn.2019100988
复制
发表时间:
2020-04-01
影响因子:
13.6
通讯作者:
Sarnak, Mark J.
中科院分区:
文献类型:
--
作者:
Drew, David A.;Tighiouart, Hocine;Sarnak, Mark J.
Background Neurocognitive testing shows that cognitive impairment is common among patients receiving maintenance hemodialysis. Identification of a well performing screening test for cognitive impairment might allow for broader assessment in dialysis facilities and thus optimal delivery of education and medical management.Methods From 2015 to 2018, in a cohort of 150 patients on hemodialysis, we performed a set of comprehensive neurocognitive tests that included the cognitive domains of memory, attention, and executive function to classify whether participants had normal cognitive function versus mild, moderate, or severe cognitive impairment. Using area-under-the-curve (AUC) analysis, we then examined the predictive ability of the Mini Mental State Examination, the Modified Mini Mental State Examination, the Montreal Cognitive Assessment, the Trail Making Test Part B, the Mini-Cog test, and the Digit Symbol Substitution Test, determining each test's performance for identifying severe cognitive impairment.Results Mean age was 64 years; 61% were men, 39% were black, and 94% had at least a high-school education. Of the 150 participants, 21% had normal cognitive function, 17% had mild cognitive impairment, 33% had moderate impairment, and 29% had severe impairment. The Montreal Cognitive Assessment had the highest overall predictive ability for severe cognitive impairment (AUC, 0.81); a score of